Genemod
Genemod provides an AI-powered, cloud-based platform unifying Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality with agentic AI for life sciences R&D. It serves pharmaceutical companies, biotech firms, academic research institutions, and clinical labs with SOC 2 Type II, HIPAA, and GDPR compliance.
- Company typePrivate
- Founded2023
- HeadquartersSeattle, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Genemod does
Genemod, Inc. is a Seattle-based, venture-backed private company that operates an AI-powered, cloud-based "Agentic Lab OS" combining Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality in a single unified platform. The product spans inventory management (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocols, Version Control, Reports), and a Genemod AI suite that includes an AI Agent capable of executing audit-logged, multi-step lab operations from a single natural-language prompt, plus AI Global Search, AI Sample Tracking, AI Protocol Template, AI Data Migration, AI Data Security, and AI-Driven Workflows. The underlying AI capabilities are built on GPT (third-party foundation model) and are designed for regulated environments managing 10M+ records, with built-in version control, audit trails, and SOC 2 Type II, HIPAA, and GDPR compliance certifications.
The platform targets life sciences R&D customers across biopharmaceutical companies, biotech startups, clinical research organizations, biorepositories, industrial biotech, biomanufacturers, contract services, academia, and diagnostics. Named enterprise and institutional users include Pfizer, Merck, Bristol Myers Squibb, AstraZeneca, Memorial Sloan Kettering, Johns Hopkins, Harvard, Stanford, Seattle Children's Research Institute, and Wisconsin State Laboratory of Hygiene, alongside biotech customers such as Antharis Therapeutics, Colossal Biosciences, Galileo, and RoverDx. The company pursues a hybrid go-to-market with a self-serve product-led growth (free signup) motion for smaller teams and startups, complemented by enterprise field sales (request-a-demo) for large pharma and research institutions.
Genemod has raised approximately $8.2 million in cumulative outside funding across three rounds (October 2020: $1.7M; August 2022: $2.0M; May 2023: $4.5M seed co-led by defy.vc and LDV Partners, with Vulcan Capital, Dolby Family Ventures, Futureland Ventures, and Looking Glass Capital participating). The company was founded by Jacob Lee (CEO) and Jin Choe (CTO). Revenue model is SaaS subscription with publicly undisclosed pricing described as "simple and predictable pricing that scales with your team," and no revenue figures are publicly disclosed.
Genemod firmographics
Firmographics- Name
- Genemod
- Legal name
- Genemod, Inc.
- Website
- https://genemod.net
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Genemod provides an AI-powered, cloud-based platform unifying Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS) functionality with agentic AI for life sciences R&D. It serves pharmaceutical companies, biotech firms, academic research institutions, and clinical labs with SOC 2 Type II, HIPAA, and GDPR compliance.
- Ownership category
- akta.pro rank
Genemod industry classification
Industry- Product category
- Lab Information Management and Electronic Lab Notebook Software
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where Genemod is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Markets served
Genemod business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Subscription: Cloud-based SaaS platform with subscription pricing model. Platform offers free signup option suggesting freemium or trial tiers, with enterprise pricing likely quote-based.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Genemod product offering
Product offeringCore offering
Genemod provides an AI-powered cloud-based Lab OS that unifies an Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) into a single platform for life sciences R&D teams. The product covers inventory and sample management, experiment and protocol documentation, order tracking, alerts, and equipment management, augmented by an agentic AI layer that executes real, audit-logged lab operations via natural language. It is sold as a SaaS subscription to pharmaceutical companies, biotech firms, clinical research organizations, biorepositories, academic institutions, and government labs.
Product overview
Genemod offers an Agentic Lab OS combining AI-powered LIMS (Laboratory Information Management System) and ELN (Electronic Lab Notebook) in one unified platform. The core portfolio includes AI LIMS, AI ELN, and AI Agent products, supplemented by AI features (Global Search, Sample Tracking, Protocol Template, Data Migration, Data Security, AI-Driven Workflows) all powered by the Genemod AI platform using GPT. Additional platform components include inventory management tools (Virtual Freezers/Sample Management, Lineage, Lab Consumables, Orders, Alerts), notebook features (Experiments, Lab Protocol, Version Control, Reports), and platform infrastructure (Security, Integrations, Equipment). The system is designed for regulated labs managing 10M+ records with built-in audit trails, compliance features, and cloud-based architecture for biopharma R&D teams.
Differentiator
Problem solved
Functional benefit
Products and services
- AI LIMS AI-powered Laboratory Information Management System that transforms lab operations, streamlines workflows, and accelerates scientific discovery through integrated inventory, sample, and equipment management. Used by biopharma R&D teams, biotech startups, clinical research, biorepositories, and academic labs.
- AI ELN AI-powered Electronic Lab Notebook with GPT integration for streamlined data access, enhanced research report quality, and experimental process optimization. Used by life sciences researchers and lab teams to capture and collaborate on experiments.
- AI Agent Natural language AI agent that executes real, audit-logged actions across inventory and notebooks through conversational commands, covering sample registration (10x faster than manual), transfers, documentation, and protocol management. Targeted at regulated labs running complex multi-step operations.
- Genemod AI Platform Core AI platform powering all Genemod AI features, enabling GPT-based assistance within the LIMS/ELN environment for search, sample tracking, protocol templating, data migration, security, and AI-driven workflows.
Quantifiable outcome
- 10x faster sample registration vs. manual click-through
- +2 more outcomes
Companies that use Genemod
Customer profileNamed customers15 records
Segments9 records
Ideal customer profiles4 records
Genemod technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature5 records
Genemod partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights6 records
Genemod competitors and assessment
Company assessmentDirect peers
- Benchling: Benchling is the leading cloud-native ELN and R&D platform for life sciences, directly competing with Genemod's AI LIMS and AI ELN products. Both target biopharma R&D teams with unified data models, audit trails, and AI-assisted workflows, making it Genemod's most direct competitor.
- LabArchives: LabArchives is a widely adopted electronic lab notebook used across academia and industry. Genemod explicitly publishes a 'LabArchives vs Genemod' comparison page, confirming it as a direct competitor for ELN and lab data management in research labs.
- Quartzy: Quartzy is a lab inventory and order management platform that overlaps with Genemod's inventory, consumables, and order-tracking modules. Genemod publishes a 'Quartzy vs Genemod' comparison page, indicating direct competition for lab operations workflows.
- Dotmatics: Dotmatics (now part of Siemens) provides a scientific R&D platform with ELN, LIMS, and inventory capabilities targeting biopharma. It competes directly with Genemod across the same primary customer segments and core product modules.
- IDBS (Danaher): IDBS offers the Polar and E-WorkBook ELN/LIMS platforms widely used in biopharma R&D and bioprocess development. It is a direct peer serving the same biopharma, industrial biotech, and CDMO customers that Genemod targets.
- Sapio Sciences: Sapio Sciences provides a unified LIMS, ELN, and scientific data management platform with growing AI capabilities. It serves biopharma and diagnostics customers comparable to Genemod's primary segments, with similar emphasis on regulated environments.
- LabVantage Solutions: LabVantage is an enterprise LIMS platform with ELN extensions used by pharma, biobanks, and manufacturing. It competes for the same regulated lab data management budget as Genemod, particularly in biomanufacturing and biorepository use cases.
- FreezerPro (Brooks Life Sciences): FreezerPro is a sample and freezer management solution used by biobanks and research labs. Genemod publishes a 'FreezerPro vs Genemod' comparison page, indicating direct overlap in virtual freezer, sample, and inventory workflows.
Broad incumbents
- Revvity Signals (formerly PerkinElmer Informatics): Revvity Signals offers the TIBCO Spotfire and Signals Notebook/Notebook+ products covering ELN, LIMS, and analytics for pharma and life sciences. It is a broad incumbent with overlapping capabilities rather than a niche specialist like Genemod.
- STARLIMS (Abbott): STARLIMS is a long-standing LIMS platform used across clinical, manufacturing, and life sciences labs. It competes in the broader LIMS category but is a generalist incumbent rather than an AI-native, life-sciences-focused platform like Genemod.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights4 records
Customer concentration
Genemod social profiles
Digital presenceGenemod compliance and trust
Trust signalCompliance3 records
Genemod financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genemod leadership team
Management profileNumber of profiles
Profiles2 records
Genemod funding detail
Funding detailFunding overview
Funding rounds3 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genemod M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genemod
What does Genemod do?
Genemod provides an AI-powered cloud-based Lab OS that unifies an Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) into a single platform for life sciences R&D teams. The product covers inventory and sample management, experiment and protocol documentation, order tracking, alerts, and equipment management, augmented by an agentic AI layer that executes real, audit-logged lab operations via natural language. It is sold as a SaaS subscription to pharmaceutical companies, biotech firms, clinical research organizations, biorepositories, academic institutions, and government labs.
Is Genemod a public or private company?
Genemod is a private company. It is classified as venture growth investor backed and is currently operating.
When was Genemod founded?
Genemod was founded in 2023. It employs 11 to 50 people.
Where is Genemod based?
Genemod is headquartered in Seattle, United States, in the North America region.
How does Genemod make money?
One revenue line is on record: saaS Subscription.
Who are Genemod's main competitors?
Direct peers on record are Benchling, LabArchives, Quartzy, Dotmatics, IDBS (Danaher), Sapio Sciences, LabVantage Solutions and FreezerPro (Brooks Life Sciences). Broad incumbents are Revvity Signals (formerly PerkinElmer Informatics) and STARLIMS (Abbott).
Does Genemod have an API?
No public API is recorded for Genemod.
What industry is Genemod in?
Genemod's product category is Lab Information Management and Electronic Lab Notebook Software. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development). Its NAICS code is 5417 and its SIC code is 7372.